Module 5 unit C Flashcards

1
Q

Ergot alkaloids

A

Dihydroergotamine

Ergotamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MOA of ergotamine

A

Alters transmission at serotonergic, dopaminergic & a-adrenergic junctions. Vasconstrictor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Ergot alkaloid indications

dihydroergotamine, ergotamine

A

Acute treatment of migraines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Triptan

A

Sumatriptan (Imitrex)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Indications of Triptans

A

Acute abortive treatment of migraines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MOA of triptans

A

Selective activation of 5HT receptors-suppresses the release of CGRP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

BBW for Ergot alkaloids

A

Potent inhibitors of CYP34A. Risk of vasospasm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Are ergot alkaloids okay for pregnancy?

A

No - contraindicated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Abortive migraine treatments

A
Triptans
Ergot alkaloids
Ditan
Oral CGRP receptor antagonist (Ubrelvy)
Analgesics (opioids, NSAIDs, APAP)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Ergot alkaloids contraindications

A

pregnancy (can cause contractions & abortion)
Do not use with triptans
Do not use in renal or liver impairment, CAD, PVD, and uncontrolled HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Oral CGRP receptor antagonist (acute treatment for HDA)

A

Ditan (Reyvow)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MOA of Ditan (Reyvow)

A

Activates 5HT1F receptor agonist - inhibits the release of neuropeptides, neurotransmitters, and inhibits the pain pathway.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ditan safety

A

Schedule V controlled substance, CNS depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

preventive (prophylactic) treatment for migraine headaches

A
Beta Blockers
TCAs
AEDs (Depakote)
Botox
CGRP monoclonal antibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treatment for migraine headaches given by injection monthly

A

CGRP monoclonal antibodies

Erenumab (Aimovig)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

MOA of Botox

A

Prevents release of acetylcholine at neuromuscular junctions

17
Q

MOA of Depakote

A

May augment inhibitory effects of GABA

18
Q

Safety with Depakote

A

Contraindicated in pregnancy

19
Q

BBW with Depakote

A

Potentially fatal pancreatitis and hepatitis Neural tube defects in developing fetus.

20
Q

Used for acute gout attacks

A

NSAIDs, Interleukin-1 inhibitors, glucocorticoids, colchicine

21
Q

used for prevention of gout

A

colchicine
urate-lowering therapy
xanthine oxidase inhibitors (allopurinol), uricosuric agent (probenecid),
recombinant uric acid oxidase (pegloticase)

22
Q

Three FDA approved drugs for fibromyalgia

A

Milnacipran
Duloxetine
pregabalin

23
Q

SNRIs for fibromyalgia

A

Milnacipran (Savella)

Duloxetine (cymbalta)

24
Q

MOA for duloxetine and milnacipran

A

Boost serotonin and norepinephrine

25
Q

Anticonvulsants for fibromyalgia

A

pregabalin (Lyrica) - grade A

Gabapentin - Grade B

26
Q

Can cause rhabdomyolysis, especially if the patient is on a statin

A

colchicine

27
Q

Helps degrade tophi in gout

Inhibits enzyme required for uric acid formation (xanthine)

A

allopurinol

28
Q

Lowers plasma urate levels by increasing iexcretion of uric acid

A

probenecid

29
Q

risk of renal stones

A

probenecid

30
Q

Warning for pegloticase

A

Do not give to patients with G6PD deficiency - can cause hemolysis and methemoglobinemia

31
Q

problem with muscle relaxants

A

Cause CNS sedation

Increase risk of falls and injury